|
Protocol
|
Title
|
ID
|
BRE09-146
Adjuvant
Breast
|
PARP Inhibition after Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer or ER/PR +, HER2 negative with known BRCA 1 / 2 Mutations
Learn More |
NCT01074970 |
NSABP B-43
Adjuvant Breast (DCIS) |
Radiation Therapy With or Without Trastuzumab in Treating Women with Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Learn More |
NCT00769379 |
NSABP B-47
Adjuvant
Breast |
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of TC or Four Cycles of AC Followed by Four Cycles of Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Normal Invasive Breast Cancer
Learn More |
NCT01275677 |
NSABP B-49
Adjuvant
Breast |
Phase III Clinical Trial Comparing the Combination of Docetaxel plus Cyclophosphamide to Anthracycline Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Learn More |
NCT01547741 |
RTOG 1005
Adjuvant
Breast |
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early- Stage Breast Cancer
Learn More |
NCT01349322 |
S1007
RxPonder
Adjuvant
Breast |
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
Learn More |
NCT01272037 |
CALGB
80702
Adjuvant
Colon |
A Phase III Trial of 6 Versus 12 Treatment of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Learn More |
NCT01150045 |
E7208
Metastatic
Colon |
A Phase II Study of Irinotecan/and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab, in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
Learn More |
NCT01079780 |
E1505
Adjuvant
Lung |
A Phase III Randomized Trial of Adjuvant Chemotherapy with or Without Bevacizumab for Patients with Completely Resected Stage IB (≥4cm) – IIIA Non-Small Cell Lung Cancer (NSCLC)
Learn More |
NCT00324805 |
E5508
Advanced
Lung |
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Learn More |
NCT01107626 |
S0819
Advanced
Lung |
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Learn More |
NCT00946712 |